Cargando…
Adaptability of AI for safety evaluation in regulatory science: A case study of drug-induced liver injury
Artificial intelligence (AI) has played a crucial role in advancing biomedical sciences but has yet to have the impact it merits in regulatory science. As the field advances, in silico and in vitro approaches have been evaluated as alternatives to animal studies, in a drive to identify and mitigate...
Autores principales: | Connor, Skylar, Li, Ting, Roberts, Ruth, Thakkar, Shraddha, Liu, Zhichao, Tong, Weida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679417/ https://www.ncbi.nlm.nih.gov/pubmed/36425225 http://dx.doi.org/10.3389/frai.2022.1034631 |
Ejemplares similares
-
DICE: A Drug Indication Classification and Encyclopedia for AI-Based Indication Extraction
por: Bhatt, Arjun, et al.
Publicado: (2021) -
DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
por: Li, Ting, et al.
Publicado: (2021) -
Corrigendum: DeepCarc: Deep learning-powered carcinogenicity prediction using model-level representation
por: Li, Ting, et al.
Publicado: (2022) -
DeepCausality: A general AI-powered causal inference framework for free text: A case study of LiverTox
por: Wang, Xingqiao, et al.
Publicado: (2022) -
InferBERT: A Transformer-Based Causal Inference Framework for Enhancing Pharmacovigilance
por: Wang, Xingqiao, et al.
Publicado: (2021)